tm logo
AI THERAPEUTICS
Live/Registered
REGISTERED

on 18 May 2021

Last Applicant/ Owned by

530 OLD WHITFIELD STREET

GUILFORD

CT

06437

Serial Number

88093745 filed on 27th Aug 2018

Registration Number

6357944 registered on 18th May 2021

in the Supplemental Register

Correspondent Address

Susan N. Acquista, Esq.

DLA Piper LLP (US)

555 Mission Street, Suite 2400

San Francisco CA 94105

Filing Basis

1. intent to use

2. use application currently

Disclaimer

"THERAPEUTICS"

AI THERAPEUTICS

Pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases "THERAPEUTICS"

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases


First Use Date in General

26th Nov 2018

First Use Date in Commerce

26th Nov 2018

Mark Details


Serial Number

No 88093745

Mark Type

No Service Mark

Attorney Docket Number

No 439275900108

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
22nd Mar 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
22nd Mar 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22nd Mar 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22nd Mar 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
22nd Mar 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
18th May 2021REGISTERED-SUPPLEMENTAL REGISTER
09th Apr 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
09th Apr 2021ASSIGNED TO LIE
09th Apr 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
08th Apr 2021USE AMENDMENT ACCEPTED